Zhen Lv1, Xianlei Cai2, Xiaoyu Weng1, Heng Xiao1, Chengli Du1, Jun Cheng1, Lin Zhou3, Haiyang Xie4, Ke Sun5, Jian Wu6, Shusen Zheng7. 1. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Collaborative Innovation Center of Diagnosis and Treatment of Infectious Diseases, Hangzhou, China. 2. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public, Hangzhou, China. 3. Collaborative Innovation Center of Diagnosis and Treatment of Infectious Diseases, Hangzhou, China. 4. Collaborative Innovation Center of Diagnosis and Treatment of Infectious Diseases, Hangzhou, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public, Hangzhou, China. 5. Department of Pathology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. 6. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Collaborative Innovation Center of Diagnosis and Treatment of Infectious Diseases, Hangzhou, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public, Hangzhou, China. Electronic address: drwujian@hotmail.com. 7. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Collaborative Innovation Center of Diagnosis and Treatment of Infectious Diseases, Hangzhou, China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public, Hangzhou, China. Electronic address: shusenzheng@zju.edu.cn.
Abstract
BACKGROUND: The stromal compartment in several organs seems to play an important role in the initiation, growth, and progression of certain neoplasms. The tumor-stroma ratio (TSR) has been found to be an independent factor for prognosis of several types of carcinomas, but the effect of the TSR on hepatocellular carcinoma (HCC) has not been explored yet. The objective of the study is to evaluate the prognostic importance of TSR in HCC patients after liver resection or transplantation. METHODS: A total of 300 patients with HCC who underwent liver resection or transplantation were included in this study. TSR was assessed on hematoxylin and eosin-stained sections by 2 independent investigators. Patients were divided into 2 groups: a stroma-rich group (stroma ≥ 50%) and a stroma-poor group (stroma < 50%). Chi-square test, Kaplan-Meier method, and Cox univariable and multivariable regression were used in to analyze the data. RESULTS: Among the post liver resection patients, the TSR was associated with overall survival (OS) in univariate and multivariate analyses (hazard ratio [HR], 4.35 [95% CI, 2.54-7.47] and HR, 2.55 [95% CI, 1.44-4.52], respectively). Among the post liver transplant patients, the TSR was also associated with OS in univariate and multivariate analyses (HR, 2.92 [95% CI, 1.63-5.23] and HR, 2.76 [95% CI, 1.47-4.85], respectively), and TSR with recurrence-free survival (RFS) in univariate and multivariate analyses (HR, 2.63 [95% CI, 1.42-4.86] and HR, 1.93 [95% CI, 1.03-3.62], respectively). Patients with stroma-poor tumor and who were within the Milan criteria or the UCSF criteria had a better in OS and RFS. CONCLUSION: We show for the first time that TSR is an independent prognostic factor for HCC patients after liver resection or transplantation. TSR may enable better identification of patients at risk for recurrence in HCC patients after curative treatment and may aid in patient management and development of individualized medicine for treatment of HCC.
BACKGROUND: The stromal compartment in several organs seems to play an important role in the initiation, growth, and progression of certain neoplasms. The tumor-stroma ratio (TSR) has been found to be an independent factor for prognosis of several types of carcinomas, but the effect of the TSR on hepatocellular carcinoma (HCC) has not been explored yet. The objective of the study is to evaluate the prognostic importance of TSR in HCCpatients after liver resection or transplantation. METHODS: A total of 300 patients with HCC who underwent liver resection or transplantation were included in this study. TSR was assessed on hematoxylin and eosin-stained sections by 2 independent investigators. Patients were divided into 2 groups: a stroma-rich group (stroma ≥ 50%) and a stroma-poor group (stroma < 50%). Chi-square test, Kaplan-Meier method, and Cox univariable and multivariable regression were used in to analyze the data. RESULTS: Among the post liver resection patients, the TSR was associated with overall survival (OS) in univariate and multivariate analyses (hazard ratio [HR], 4.35 [95% CI, 2.54-7.47] and HR, 2.55 [95% CI, 1.44-4.52], respectively). Among the post liver transplant patients, the TSR was also associated with OS in univariate and multivariate analyses (HR, 2.92 [95% CI, 1.63-5.23] and HR, 2.76 [95% CI, 1.47-4.85], respectively), and TSR with recurrence-free survival (RFS) in univariate and multivariate analyses (HR, 2.63 [95% CI, 1.42-4.86] and HR, 1.93 [95% CI, 1.03-3.62], respectively). Patients with stroma-poor tumor and who were within the Milan criteria or the UCSF criteria had a better in OS and RFS. CONCLUSION: We show for the first time that TSR is an independent prognostic factor for HCCpatients after liver resection or transplantation. TSR may enable better identification of patients at risk for recurrence in HCCpatients after curative treatment and may aid in patient management and development of individualized medicine for treatment of HCC.
Authors: Sarah Ouahoud; Philip W Voorneveld; Lukas J A C Hawinkels; James C H Hardwick; Lennart R A van der Burg; Eveline S M de Jonge-Muller; Mark J A Schoonderwoerd; Madelon Paauwe; Thijs de Vos; Sophie de Wit; Gabi W van Pelt; Wilma E Mesker Journal: Oncogene Date: 2020-01-23 Impact factor: 9.867
Authors: Hannah Panayiotou; Nicolas M Orsi; Helene H Thygesen; Alexander I Wright; Matthew Winder; Richard Hutson; Michele Cummings Journal: BMC Cancer Date: 2015-12-16 Impact factor: 4.430
Authors: F J Vogelaar; G W van Pelt; A M van Leeuwen; J M Willems; R A E M Tollenaar; G J Liefers; W E Mesker Journal: Cell Oncol (Dordr) Date: 2016-09-09 Impact factor: 6.730